A nationwide seroepidemiology of hepatitis C virus infection in South Korea

Liver International

Volumn 33, Issue 4, 2013, Pages 586-594

  Kim, Do Young ^a   Kim, In Hee ^b   Jeong, Sook Hyang ^c   Cho, Yong Kyun ^d   Lee, Joon Hyoek ^e   Jin, Young Joo ^f   Lee, Don ^f   Suh, Dong Jin ^f   Han, Kwang Hyub ^a   Park, Neung Hwa ^g   Kang, Ha Yan ^h   Jung, Young Kul ⁱ   Kim, Young Seok ^j   Kim, Kyung Ah ^k   Lee, Youn Jae ^l   Lee, Byung Seok ^m   Yim, Hyung Joon ⁿ   Lee, Heon Ju ^o   Baik, Soon Koo ^p   Tak, Won Young ^q   Lee, Sun Jae ^r   Chung, Woo Jin ^s   Choi, Sung Kyu ^t   Cho, Eun Young ^u   Heo, Jeong ^v   Kim, Dong Joon ^w   Song, Byung Cheol ^x   Kim, Man Woo ^y   Lee, Jun ^y   Chae, Hee Bok ^z   Choi, Dae Hee ^aa   Choi, Hwa Young ^ab   Ki, Moran ^ab   more..

^a Yonsei University College of Medicine   (South Korea)

^b Chonbuk National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Samsung Medical Center   (South Korea)

^f Asan Medical Center   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Dankook University College of Medicine   (South Korea)

ⁱ Gacheon University   (South Korea)

^j Soonchunhyang University College of Medicine   (South Korea)

^k Inje University   (South Korea)

^l Inje University College of Medicine   (South Korea)

^m Chungnam National University   (South Korea)

ⁿ Korea University College of Medicine   (South Korea)

^o Yeungnam University College of Medicine   (South Korea)

^p Yonsei University Wonju College of Medicine   (South Korea)

^q Kyungpook National University School of Medicine   (South Korea)

^r Korea University College of Medicine   (South Korea)

^s Keimyung University School of Medicine   (South Korea)

^t Chonnam National University Medical School   (South Korea)

^u Wonkwang University   (South Korea)

^v Pusan National University School of Medicine   (South Korea)

^w Hallym University College of Medicine   (South Korea)

^x Jeju National University School of Medicine   (South Korea)

^y Chosun University   (South Korea)

^z Chungbuk National University College of Medicine   (South Korea)

^aa Kangwon National University   (South Korea)

^ab Eulji University School of Medicine   (South Korea)

more..

Author keywords

Hepatitis C virus; Infection; Korea; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; FEASIBILITY STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROEPIDEMIOLOGY; SOUTH KOREA; TREATMENT RESPONSE;

ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RESIDENCE CHARACTERISTICS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875054629     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12108     Document Type: Article

References (32)

1. Sievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia, and Egypt. Liver Int 2011; 31(Suppl 2): 61-80.
2. Lauer G, Walker B. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
4. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
5. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011; 31: 1090-101.
6. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36: S93-8.
7. Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31(Suppl 2): 30-60.
8. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138: 513-21.
9. Esteban JI, Sauleda S, Ouer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-62.
10. Baatarkhuu O, Kim DY, Ahn SH, et al. Prevalence and genotype distribution of hepatitis C among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int 2008; 28: 1389-95.
11. Soriano V, Vispo E, Poveda E, et al. Directly acting antivirals against hepatitis C virus. J Antimicrob Chemother 2011; 66: 1673-86.
12. Ahn SH, Yuen L, Han KH, et al. Molecular and clinical characteristics of hepatitis B virus in Korea. J Med Virol 2010; 82: 1126-34.
13. Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology 2006; 49: 18-22.
14. Kim BK, Han KH, Park JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010; 105: 1382-90.
15. Flisiak R, Halota W, Horban A, et al. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol 2011; 23: 1213-7.
16. Chowdhury A, Santra A, Chaudhury S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bangal, India. Hepatology 2003; 37: 802-9.
17. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-11.
18. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
19. Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 2012; 55: 447-54.
20. Marzouk D, Sass J, Bakr I, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007; 56: 1105-10.
21. Siagris D, Christofidou M, Theocharis GJ, et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 2006; 13: 56-61.
22. Ramcharran D, Wahed AS, Conjeevaram HS, et al. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort. J Viral Hepat 2011; 18: 144-52.
23. Corey KE, Kane E, Munroe C, et al. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology 2009; 50: 1030-7.
24. Dai CY, Chuang WL, Ho CK, et al. Association between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 2008; 49: 9-16.
25. Antonelli A, Ferri C, Fallahi P, et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563-72.
26. Lee MH, Yang HI, Jen CL, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23, 820 residents in Taiwan in 1991-2. Gut 2011; 60: 688-94.
27. Oh DJ, Park YM, Seo YI, Lee JS, Lee JY. Prevalence of hepatitis C virus infections and distribution of hepatitis C virus genotypes among Korean blood donors. Ann Lab Med 2012; 32: 210-5.
28. Butt AA, Justice AC, Skanderson M, et al. Rate and predictors of treatment prescription for hepatitis C. Gut 2007; 56: 385-9.
29. Butt AA, Wagener M, Shakil AO, Ahmad J. Reasons for non-treatment of hepatitis C in veterans in care. J Viral Hepat 2005; 12: 81-5.
30. Park SH, Park CK, Lee JW, et al. Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatmet of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study. Gut Liver 2012; 6: 98-106.
31. Afdhal NH, McHutchison JG, Zeuzem S, et al. Hepatitis C pharmacogenetics: State of the art in 2010. Hepatology 2011; 53: 336-45.
32. Korea Center for Disease Control and Prevention. Korea National Health and Nutrition Examination Survey. Available at http://knhanes.cdc.go.kr/. Accessed 18 March 2011.